Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1859 1
1864 1
1899 1
1900 1
1918 1
1942 1
1944 1
1946 1
1949 1
1950 6
1951 1
1952 5
1953 4
1954 7
1956 1
1957 3
1958 2
1959 2
1960 3
1961 17
1962 3
1963 22
1964 31
1965 32
1966 31
1967 19
1968 24
1969 13
1970 21
1971 6
1972 9
1973 25
1974 18
1975 42
1976 40
1977 42
1978 44
1979 47
1980 64
1981 43
1982 55
1983 62
1984 58
1985 60
1986 78
1987 97
1988 115
1989 151
1990 163
1991 159
1992 199
1993 173
1994 202
1995 279
1996 312
1997 410
1998 509
1999 615
2000 785
2001 834
2002 927
2003 1150
2004 1284
2005 1413
2006 1643
2007 1862
2008 1918
2009 2027
2010 2274
2011 2436
2012 2551
2013 2825
2014 3416
2015 4046
2016 4470
2017 4572
2018 5122
2019 5375
2020 6272
2021 7143
2022 7084
2023 7079
2024 3158

Text availability

Article attribute

Article type

Publication date

Search Results

75,967 results

Results by year

Filters applied: . Clear all
Page 1
Study protocol for a randomized controlled trial of supportive parents - coping kids (SPARCK)-a transdiagnostic and personalized parent training intervention to prevent childhood mental health problems.
Tømmerås T, Backer-Grøndahl A, Høstmælingen A, Laland H, Gomez MB, Apeland A, Karlsson LRA, Grønlie AA, Torsvik S, Bringedal GE; Advisory Consortium; Monica A, Fisher PA, Gardner F, Kjøbli J, Malmberg-Heimonen I, Nissen-Lie HA. Tømmerås T, et al. BMC Psychol. 2024 May 13;12(1):264. doi: 10.1186/s40359-024-01765-y. BMC Psychol. 2024. PMID: 38741201 Clinical Trial.
It is a two-armed parallel group randomized controlled effectiveness and superiority trial with 252 families randomly allocated to SPARCK or UC. Assessment of key variables will be conducted at pre-, post-, and six-month follow-up. DISCUSSION: The current study will contri …
It is a two-armed parallel group randomized controlled effectiveness and superiority trial with 252 families randomly allocated to SPARCK or …
Overcoming barriers in cancer care for gender minorities.
Benjamin DJ, Yazdanpanah O, Rezazadeh Kalebasty A. Benjamin DJ, et al. Nat Rev Urol. 2024 May 13. doi: 10.1038/s41585-024-00894-8. Online ahead of print. Nat Rev Urol. 2024. PMID: 38740971 No abstract available.
Themes, Rates, and Risk of Adverse Events of the Artificial Pancreas in the United States Using MAUDE.
Ferguson AM, Lin AC. Ferguson AM, et al. Ann Biomed Eng. 2024 May 13. doi: 10.1007/s10439-024-03529-6. Online ahead of print. Ann Biomed Eng. 2024. PMID: 38740730
While the artificial pancreas is still in its infancy, these event rates are not at an acceptable level for a device which can precipitate death from malfunctions. Further exploration into safety events and much more research and development is needed for devices to reduce …
While the artificial pancreas is still in its infancy, these event rates are not at an acceptable level for a device which can precipitate d …
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.
Arrigo M, Davison B, Edwards C, Adamo M, Ambrosy AP, Barros M, Biegus J, Celutkiene J, Čerlinskaitė-Bajorė K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Voors AA, Cotter G, Mebazaa A. Arrigo M, et al. Am Heart J. 2024 May 11:S0002-8703(24)00106-6. doi: 10.1016/j.ahj.2024.04.019. Online ahead of print. Am Heart J. 2024. PMID: 38740532
BACKGROUND: The STRONG-HF trial showed that high-intensity care (HIC) consisting of rapid up-titration of guideline-directed medical therapy (GDMT) and close follow-up reduced all-cause death or heart failure (HF) readmission at 180 days compared to usual care (UC). We hyp …
BACKGROUND: The STRONG-HF trial showed that high-intensity care (HIC) consisting of rapid up-titration of guideline-directed medical therapy …
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial.
Necchi A, Roumiguié M, Kamat AM, Shore ND, Boormans JL, Esen AA, Lebret T, Kandori S, Bajorin DF, Krieger LEM, Niglio SA, Uchio EM, Seo HK, de Wit R, Singer EA, Grivas P, Nishiyama H, Li H, Baranwal P, Van den Sigtenhorst-Fijlstra M, Kapadia E, Kulkarni GS. Necchi A, et al. Lancet Oncol. 2024 May 10:S1470-2045(24)00178-5. doi: 10.1016/S1470-2045(24)00178-5. Online ahead of print. Lancet Oncol. 2024. PMID: 38740030
75,967 results
You have reached the last available page of results. Please see the User Guide for more information.